The Allergan and Pfizer logos appear above a trading post on the floor of the New York Stock Exchange, Nov. 23. The two companies are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world’s largest drugmaker. (Richard Drew, The Associated Press)
Re: “End corporate inversions by reforming the tax code,” Nov. 29 Bloomberg View editorial.
Regarding the merger of Allergan and Pfizer and the company’s plan to headquarter in Ireland, I suggest U.S. companies that want to avoid paying U.S. taxes by changing their addresses to another country be made to pay tariffs on all the products they sell in the United States. That should make up for the corporate taxes they seek to avoid.
Kathleen Flynn, Arvada
This letter was published in the Dec. 4 edition.
Submit a letter to the editor via this form or check out our guidelines for how to submit by e-mail or mail.
